PHOTO CREDIT: SHUTTERSTOCK

UM Virologist Peter Pelka is developing a recombinant vaccine to combat SARS-COV-2

Posted on

It’s a thrilling process, akin to running a marathon, hundreds of researchers race alongside to find a cure or a vaccine. The qualifying process is lengthy and complex.

If an effective vaccine is found, determining its duration of protection, how often immunization will be necessary, (once a year, or every ten years), and whether it’s safe, are all questions which researchers must ensure they have answers to before a vaccine can be deployed…..

https://news.umanitoba.ca/um-virologist-peter-pelka-is-developing-a-recombinant-vaccine-to-combat-sars-cov-2/

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]